← back to search

Kawsar R. Talaat

Johns Hopkins University · US
Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include SARS-CoV-2 and COVID-19 Research, Escherichia coli research studies, Influenza Virus Research Studies, and Viral gastroenteritis research and epidemiology.
h-index
30
citations
3,761
works
98
NIH funding
—
primary concept
Medicine
email
ktalaat@jhu.edu

Recent publications

Case Series of Thrombosis With Thrombocytopenia Syndrome After COVID-19 Vaccination—United States, December 2020 to August 2021
Annals of Internal Medicine 2022cited by 149position: middledoi
Evaluation of the BNT162b2 Covid-19 Vaccine in Children 5 to 11 Years of Age
New England Journal of Medicine 2021cited by 621position: middledoi
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021
JAMA 2021cited by 545position: middledoi
The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model
Science Translational Medicine 2016cited by 256position: middledoi
Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults
PLoS ONE 2016cited by 136position: firstdoi
A Single Dose of Any of Four Different Live Attenuated Tetravalent Dengue Vaccines Is Safe and Immunogenic in Flavivirus-naive Adults: A Randomized, Double-blind Clinical Trial
The Journal of Infectious Diseases 2013cited by 166position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anna P. Durbin · Johns Hopkins University4 papers (2013–2021)Noreen A. Hynes · International Society of Travel Medicine3 papers (2013–2016)Stephen S. Whitehead · National Institutes of Health2 papers (2013–2016)Kathryn M. Edwards · Compliant Concept2 papers (2021–2022)Karen R. Broder · Centers for Disease Control and Prevention2 papers (2021–2022)Catherine J. Luke · National Institute of Allergy and Infectious Diseases2 papers (2013–2016)Allison P. Wheeler · University of Washington2 papers (2021–2022)Adamma Mba‐Jonas · United States Food and Drug Administration2 papers (2021–2022)Victor Urrutia · Anna Needs Neuroblastoma Answers2 papers (2021–2022)Shannon C. Walker · Vanderbilt University2 papers (2021–2022)Isaac See · Centers for Disease Control and Prevention2 papers (2021–2022)Michael B. Streiff · Sidney Kimmel Comprehensive Cancer Center2 papers (2021–2022)Marya P. Carmolli · University of Virginia2 papers (2013–2016)Kristen K. Pierce · University of Vermont2 papers (2013–2016)Beth D. Kirkpatrick · University of Virginia2 papers (2013–2016)— · 2 papers (2013–2016)Emily Jane Woo · Computer Technology Associates (United States)2 papers (2021–2022)John R. Su · National Center for Emerging and Zoonotic Infectious Diseases2 papers (2021–2022)Catherine J. Larsson · University of Vermont2 papers (2013–2016)Allison Lale · Centers for Disease Control and Prevention2 papers (2021–2022)